Learn how CHOP’s dedicated CDH team translates research findings into care advances that improve the lives of children with this condition.

CHOP has a team of full-time genetic counselors dedicated only to fetal patients. Learn how they support families in prenatal counseling.

Phase three of the Management of Myelomeningocele Study (MOMS), known as “MOMS3,” is a study monitoring the health outcomes of participants ages15-24.

CHOP researchers have led an international group of experts in developing new guidelines for neonatal resuscitation research.

More than 14 years after opening the Garbose Family Special Delivery Unit, the world’s first birth facility exclusively for mothers carrying babies with known birth defects, Children’s Hospital of Philadelphia celebrates its 5,000th delivery.

Meet Eric Chien-Wei Liao, MD, PhD, founding Director of the Center for Craniofacial Innovation at Children’s Hospital of Philadelphia (CHOP).

Children’s Hospital of Philadelphia (CHOP) has appointed Michael L. Nance, MD as the Chief of the Division of Pediatric General, Thoracic, and Fetal Surgery, effective July 1, 2022.

Yearly event was back in person after two-year virtual hiatus, gathering patients and families who were treated in the Center for Fetal Diagnosis and Treatment.

CHOP’s Department of Surgery has been led by surgical pioneers who’ve played a seminal role in shaping the practice of pediatric and fetal surgery worldwide.

Care of agenesis of the corpus callosum involves a multidisciplinary approach, from prenatal consultation to delivery and care coordination with various specialists for long-term follow-up to monitor neurodevelopmental outcomes.